CoreSite Realty

Yahoo Finance • 11 days ago

Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus

Last week, major U.S. indexes ended the Christmas-shortened week higher, with the S&P 500 and the Dow attaining new record highs. The S&P 500, the Dow Jones Industrial Average and the tech-heavy Nasdaq Composite gained 0.75%, 0.72% and 0.7... Full story

Yahoo Finance • 11 days ago

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of the iDose TR launch and a robust product pipeline. However, stiff competition is a concern. Shares of this Zacks Rank #3 (Hold) company have gained 12.5% so far this year c... Full story

Yahoo Finance • 25 days ago

Sector Update: Health Care Stocks Gain Late Afternoon

Health care stocks rose late Monday afternoon with the NYSE Health Care Index gaining 1.2% and the S PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 25 days ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

Health care stocks rose Monday afternoon, with the NYSE Health Care Index up 0.9% and the State Stre PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 25 days ago

Cencora to Buy Majority Stake in OneOncology for $5 billion

Cencora (COR) said Monday that it agreed to acquire majority of the stake it doesn't already own in PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: UnitedHealth, Eli Lilly, and Bristol Myers in focus

Wall Street's major averages closed in the green on Friday, as traders assessed fresh inflation data in hopes of gauging the Federal Reserve's monetary policy. The benchmark S&P 500 closed +0.2%, while the Nasdaq Composite ended +0.3%, an... Full story

Yahoo Finance • last month

JPMorgan Raises Cencora (COR) Price Target After Financial Model Update

Cencora, Inc. (NYSE:COR) is included among the 15 Dividend Stocks that Outperform the S&P 500.JPMorgan Raises Cencora (COR) Price Target After Financial Model Update Photo by Dan Dennis on Unsplash On November 11, JP⁠Mor⁠gan raised its p... Full story

Yahoo Finance • last month

Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities

Expanded capabilities in Europe and the United States enable company to deliver enhanced third-party logistics support to pharmaceutical companies CONSHOHOCKEN, Pa., December 03, 2025--(BUSINESS WIRE)--Cencora, a global pharmaceutical sol... Full story

Yahoo Finance • last month

COR Quantitative Stock Analysis

Below is Validea's guru fundamental report for CENCORA INC (COR). Of the 22 guru strategies we follow, COR rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks... Full story

Yahoo Finance • 2 months ago

Validea Detailed Fundamental Analysis - COR

Below is Validea's guru fundamental report for CENCORA INC (COR). Of the 22 guru strategies we follow, COR rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks... Full story

Yahoo Finance • 2 months ago

Cencora Inc (COR) Q4 2025 Earnings Call Highlights: Strategic Investments Propel Growth Amid ...

This article first appeared on GuruFocus. Release Date: November 05, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Cencora Inc (NYSE:COR) reported a 16% growth... Full story

Yahoo Finance • 2 months ago

Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast

By Padmanabhan Ananthan (Reuters) -Cencora will invest over $1 billion through 2030 to expand its U.S. network, the drug distributor said on Wednesday, after forecasting adjusted profit for next year above Wall Street expectations. The c... Full story

Yahoo Finance • 2 months ago

Cencora eying $1B investment to boost U.S. supply chain

[Pharmaceutical.] artisteer/iStock via Getty Images Drug distributor Cencora (COR [https://seekingalpha.com/symbol/COR]) is looking to invest $1B through 2030 to strengthen its U.S. supply chain, the company said on Wednesday as it report... Full story

Yahoo Finance • 2 months ago

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

Revenue of $83.7 Billion for the Fourth Quarter, a 5.9 Percent Year-Over-Year Increase Fourth Quarter GAAP Diluted EPS of $(1.75) and Adjusted Diluted EPS of $3.84 Revenue of $321.3 Billion for Fiscal Year 2025, a 9.3 Percent Year-Over-Y... Full story

Yahoo Finance • 2 months ago

Pre-Market Earnings Report for November 5, 2025 : MCD, EMR, JCI, COR, SRE, CCJ, HUM, TRGP, FIS, IRM, PPL, FWONK

The following companies are expected to report earnings prior to market open on 11/05/2025. Visit our Earnings Calendar for a full list of expected earnings releases. McDonald's Corporation (MCD)is reporting for the quarter ending Sept... Full story

Yahoo Finance • 2 months ago

A Fresh Look at Cencora (COR) Valuation as Shares Rally 8% in the Past Month

Cencora (COR) shares continue to climb, gaining around 1% in the past day and up over 8% for the month. Investors seem to be weighing the company’s strong revenue and net income growth in light of broader market trends. See our latest ana... Full story

Yahoo Finance • 3 months ago

Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US

DETROIT, October 16, 2025--(BUSINESS WIRE)--Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in partnership with Handa Therapeutics, LLC, and will be exclusively available thr... Full story

Yahoo Finance • 3 months ago

Does Cencora’s Strong 42% Rally Signal More Growth Ahead in 2025?

If you’re standing at a crossroads, wondering what to do with Cencora stock, you’re not alone. With shares closing recently at $318.00 and quietly notching up a 42.6% gain over the past year, there’s a real sense of momentum. The stock out... Full story

Yahoo Finance • 3 months ago

Notable healthcare headlines for the week: Novo Nordisk, Bristol Myers Squibb and J&J in focus

Tom Werner Wall Street's major averages plummeted on Friday after U.S. President Donald Trump threatened higher tariffs to China, saying it had "become very hostile" sending letters to other countries wanting to "impose export controls."... Full story

Yahoo Finance • 3 months ago

Bitcoin Miner Leads Two Health Care Stocks To New Highs

Core Scientific hit an all-time high in Friday's stock market. Shares are on a three-day winning streak and just above a cup base's buy point of 18.21, making the company one that's reaching new highs and worth watching. Its relative stren... Full story